Treatment of male breast cancer: meta-analysis of real-world evidence
- 1 September 2021
- journal article
- review article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 108 (9), 1034-1042
- https://doi.org/10.1093/bjs/znab279
Abstract
Background: Breast cancer is rare in men and managed by extrapolating from breast cancer in women. The clinicopathological features of male breast cancer, however, differ from those of female breast cancer. Because clinical trials are rare, the synthesis of real-world data is one method of integrating sufficient evidence on the optimal treatment for this patient population. Methods: PubMed, Embase, and Cochrane Library databases were searched. Clinical studies were included if they evaluated the treatments of interest in male breast cancer; these evaluations included breast-conserving surgery (BCS) versus mastectomy, postmastectomy radiation therapy versus no radiation, the accuracy of sentinel lymph node biopsy (SLNB), and a comparison of various endocrine therapies. Results: Forty studies were retrieved. The pooled estimate of overall survival (OS) revealed no difference between BCS and mastectomy groups. Postmastectomy radiation to the chest wall significantly increased OS relative to no postmastectomy radiation (hazard ratio (HR) 0.67, 95 per cent confidence interval 0.54 to 0.84). The pooled estimates of identification and false-negative rates of SLNB were 97.4 and 7.4 per cent respectively. Tamoxifen treatment was associated with significantly increased OS compared with no tamoxifen intake (HR 0.62, 0.41 to 0.95). Conclusion: Identification and false-negative rates for SLNB were comparable to those in female breast cancer. Breast-conserving surgery can be effective and safe; postmastectomy radiation to the chest wall and 5-year tamoxifen treatment improves survival.This publication has 61 references indexed in Scilit:
- Localized Therapy for Male Breast Cancer: Functional Advantages With Comparable Outcomes Using Breast ConservationClinical Breast Cancer, 2013
- Male Breast Cancer: 20-Year Survival Data for Post-Mastectomy RadiotherapyBreast Care, 2013
- Tamoxifen adherence and its relationship to mortality in 116 men with breast cancerBreast Cancer Research and Treatment, 2012
- Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trialsThe Lancet, 2011
- Breast conserving surgery with preservation of the nipple-areola complex as a feasible and safe approach in male breast cancer: a case reportJournal of Medical Case Reports, 2008
- The Lymphatic Anatomy of the Breast and its Implications for Sentinel Lymph Node Biopsy: A Human Cadaver StudyAnnals of Surgical Oncology, 2007
- Sentinel Lymph Node Biopsy in Male Patients with Early Breast CancerThe Oncologist, 2007
- Male breast cancer: a review of clinical managementBreast Cancer Research and Treatment, 2006
- Adjuvant systemic therapy for male breast carcinomaCancer, 2005
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986